瘤微环境中的双阳性细胞
Xinmiao Long1,2,3, Yinfei Du1,2,3, Yinan Li1,2,3
1The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Central South University, Changsha, Hunan Province, China.
Journal of translational internal medicine
|February 23, 2026
概括
双阳性细胞 (DPC) 在瘤微环境中至关重要,影响癌症的进展和治疗耐药性. 针对这些细胞提供了潜在的新癌症疗法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症免疫学 癌症免疫学
背景情况:
- 瘤微环境 (TME) 是一个复杂的生态系统,影响癌症的进展.
- 在TME内部的相互作用涉及免疫细胞,纤维细胞,内皮细胞和介质细胞.
- 双阳性细胞 (DPC) 已经成为TME的关键组成部分.
研究的目的:
- 审查DPCs的形成,表征,分类,功能和临床意义.
- 突出DPCs在癌症进展和治疗耐药性的作用.
- 探索针对新型癌症治疗的DPC的潜力.
主要方法:
- 对DPCs最近研究的文献综述.
- 对DPC特征和TME中的功能进行分析.
- 对DPCs在癌症中的临床影响的评估.
主要成果:
- DPCs是由来自不同细胞系的标记物的共同表达来定义的.
- DPCs有助于增强瘤的侵入性和免疫逃避.
- DPCs在促进癌症抗药性方面发挥着重要作用.
结论:
- DPCs是瘤微环境中的重要参与者,影响癌症的多个方面.
- 针对DPCs是一个有前途的策略,用于开发新的癌症疗法.
- 对DPC的进一步研究可能会彻底改变癌症治疗方法.
更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
15.6K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.2K
相关概念视频
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:40Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K